J Allergy Clin Immunol Glob. 2024 Jul 26;3(4):100313. doi: 10.1016/j.jacig.2024.100313. eCollection 2024 Nov.
ABSTRACT
Prompt evaluation and genetic testing of patients who present with recurrent and recalcitrant warts, before onset of severe infection or myelodysplastic syndrome, leads to improved outcomes in patients with GATA2 deficiency.
PMID:39221430 | PMC:PMC11364118 | DOI:10.1016/j.jacig.2024.100313
